Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04715828
Other study ID # 2020 PONS-REJRAJI
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date January 1, 2022

Study information

Verified date January 2021
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre, PharmD
Phone 04 73 75 49 63
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Differentiated thyroid cancer is the third cause of cancer in young men of childbearing age. Its treatment by irradiation with Radioactive Iodine 131 therapy (RAT) could alter spermatogenesis and result in azoospermia and permanent infertility. A preventive gametes cryopreservation was recommended before RAT, but without mentioning a period of teratogenic risk transmissible to the offspring. To date, RAT impact on human sperm nucleus is poorly known or even unknown, notably on telomere length. Our objective is to define RAT effects on human sperm nucleus by in vitro irradiation exposure of human spermatozoa to mimicking that of the gonads in the context of irradiation with iodine131 used for thyroid cancer. We will analyze standard sperm parameters, major DNA alterations and telomere length using molecular and cellular assays. Nucleus morphology and chromatin organization will also be analyzed using 3D bio-imaging. This study will permit to optimize the indications for the preservation of fertility.


Description:

Our main objective is to measure the in vitro impact of irradiation treatment on sperm nuclear quality such as DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and notably sperm telomere length (STL). The secondary objectives are : - to measure RAT impact on sperm parameters (vitality, motility and morphology) - to measure the impact of cryopreservation on chromatin organisation and nucleus morphology - to evaluate RAT impact on human sperm cells in comparison with cryopreservation - to evaluate the impact of different doses and types of irradiation on human sperm cells - to establish relations between potential alterations of standards sperm parameters (vitality, motility and morphology) and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL. Our final goal is to provide a significant improvement of men fertility diagnosis and optimize our fertility preservation practices. To this end, we will expose ejaculated human spermatozoa (n = 90) at different (low and moderate) doses of gamma or X photons to mimic gonads irradiation. Absorbed doses by the samples were calculated using the GATE Monte Carlo platform (version 8.2). Experiment geometry settings were modelled as three dimension voxelized volumes inside the software by assigning a shape, size, distance and density for all the volumes created. All measurements will be made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples are collected and subdivided into 3 arms to analyse sperm quality after: - irradiation exposure (3 conditions); - a freezing- thawing cycle; - fresh state: negative control without treatment. Before (fresh state) and after each treatment we will analyse: - standard semen parameters (vitality, motility and morphology) in accordance with WHO, 2010; - STL using Flow FISH, q-PCR and q-FISH; - chromatin condensation (chromomycin A3); - DNA oxidization (8-OHdG residues); - DNA fragmentation (TUNEL); - 3D nucleus structure using 3D bio-imaging.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 1, 2022
Est. primary completion date January 1, 2022
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Man less than 45 years - Man undergoing routine semen analysis at the Center for Reproductive Medicine, accepting the research protocol and signing the associated consent will be included in the protocol without distinction of physical criteria. Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cryopreserved semen
sperm will be frozen in Cryosperm® cryoprotectant medium (Origio). The samples will be packaged in previously identified high security straws (Cryobiosystem). Slow freezing of the straws will be carried out using the Nanodigicool® programmable device (Cryobiosystem).
Acute and low irradiation
sperm sample will be placed on the scanner's processing table to be exposed for 1 to 2 seconds. Several dose levels will then be made in order to limit the value of 17 mGy
Long and low irradiation
sperm sample will be exposed to gamma radiation by adding a solution of Tc99m for 3 hours.
Long and medium irradiation
sperm sample will be exposed to gamma radiation by adding a solution of I131 for 3 hours

Locations

Country Name City State
France CHU de Clermont-Ferrand Clermont-Ferrand

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Agence de La Biomédecine

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To measure in vitro the impact of an ionizing radiation treatment on sperm nuclear quality and in particular the size of telomeres. To achieve this goal, we will expose human sperm to an irradiation dose of I131 to mimic the irradiation of gonads and sperm. Reliquat of semen will be cryopreserved (control condition). After thawing, the same sample will be subdivised into 2 groups in order to analyze the sperm quality :
After an irradiation dose of I131
After a cryopreservation
01/01/2018-01/01/2022
Secondary To measure in vitro the impact of an irradiation dose of I131 on sperm nuclear quality, notably on STL. All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
irradiation exposure (3 conditions);
a freezing- thawing cycle;
fresh state: negative control without treatment.
Before (fresh state) and after each treatment we will analyse:
STL using Flow FISH, q-PCR and q-FISH;
chromatin condensation (chromomycin A3);
DNA oxidization (8-OHdG residues);
DNA fragmentation (TUNEL);
3D nucleus structure using 3D bio-imaging.
01/01/2018-01/01/2022
Secondary to measure RAT impact on sperm parameters (vitality, motility and morphology) All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
irradiation exposure (3 conditions);
a freezing- thawing cycle;
fresh state: negative control without treatment.
a freezing- thawing cycle;
fresh state: negative control without treatment. Before (fresh state) and after each treatment we will analyse standard semen parameters (vitality, motility and morphology) in accordance with WHO, 2010;
01/01/2018-01/01/2022
Secondary To measure in vitro the impact of cryopreservation on sperm nuclear quality, notably on STL, chromatin organisation and nucleus morphology All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
irradiation exposure (3 conditions);
a freezing- thawing cycle;
fresh state: negative control without treatment.
Before (fresh state) and after each treatment we will analyse:
STL using Flow FISH, q-PCR and q-FISH;
chromatin condensation (chromomycin A3);
DNA oxidization (8-OHdG residues);
DNA fragmentation (TUNEL);
3D nucleus structure using 3D bio-imaging.
01/01/2018-01/01/2022
Secondary to evaluate RAT impact on human sperm cells in comparison with cryopreservation We will compare effects induced by RAT and cryopreservation on each sperm sample. In order to limit the bias, for each irradiation treatment, a sample of sperm cells (cryopreserved control) will be treated under identical conditions. 01/01/2018-01/01/2022
Secondary to evaluate the impact of different doses and types of irradiation on human sperm cells All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
irradiation exposure (3 conditions);
a freezing- thawing cycle;
fresh state: negative control without treatment.
Irradiation exposure will be realised under 3 conditions:
acute and low irradiation : sperm sample will be placed on the scanner's processing table to be exposed for 1 to 2 seconds. Several dose levels will then be made in order to limit the value of 17 mGy.
long and low irradiation: sperm sample will be exposed to gamma radiation by adding a solution of Tc99m for 3 hours.
long and medium irradiation : sperm sample will be exposed to gamma radiation by adding a solution of I131 for 3 hours
01/01/2018-01/01/2022
Secondary to establish relations between potential alterations of standards sperm parameters (vitality, motility and morphology) and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL. We will correlate the effects induced by on vitality, motility and morphology and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL. 01/01/2018-01/01/2022